Brief: Targovax ASA And Agenus Announce Collaboration On Mutant KRAS Cancer Vaccine Adjuvanted With QS-21 STIMULON™

Circio Holding ASA

07/03/2022 12:48

March 7 (Reuters) - Agenus Inc  AGEN.O :
    * TARGOVAX ASA AND AGENUS ANNOUNCE COLLABORATION ON MUTANT
KRAS
CANCER VACCINE ADJUVANTED WITH QS-21 STIMULON™
    * AGENUS - AGREEMENT MAY BE EXTENDED INTO EXCLUSIVE
COMMERCIAL
PARTNERSHIP FOR KRAS VACCINATION IF COMBINATION PROVES EFFECTIVE
IN EXPLORATORY CLINICAL STUDIES
    * AGENUS - UNDER DEAL, CO WILL SUPPLY QS-21 STIMULON &
SCIENTIFIC
SUPPORT FOR UP TO THREE INITIAL TG01 CLINICAL TRIALS IN
DIFFERENT CANCER INDICATIONS

Source text for Eikon:  ID:nGNX1Sr0k7 
Further company coverage:  AGEN.O 

 ((Reuters.Briefs@thomsonreuters.com;))